Locations:
Search
Challenges include multimorbidity, polypharmacy, limited mobility and sarcopenia
Meta-analyses signal an opportunity to reshape risk stratification and surgical protocols for these comorbidities
Use of GLP-1s and improving cardiovascular health lowers risk of hematologic malignancies
Consider each patient's unique disease progression and treatment goals when choosing a strategy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New papers review the data and provide guidance on antiobesity medications and other options
Patient loses 148 pounds in 18 months, reduces BMI to 26
Findings show greater reduction in CKD progression, kidney failure than GLP-1RAs
A weight-management program plus anti-obesity medication performs well
Cleveland Clinic study finds that durable weight loss is key to health benefits
Comprehensive approach can make a transformative impact
Advertisement
Advertisement